R&D Systems Inc. Tocris Bioscience Boston Biochem

G-1

Cat. No. 3577

G-1 C21H18BrNO3 [881639-98-1]

Price and Availability

For G-1 pricing & availability please select your country from the drop down menu:
Submit
By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Chemical Name: (±)-1-[(3aR*,4S*,9bS*)-4-(6-Bromo-1,­3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclop­enta[c]quinolin-8-yl]- ethanone

Biological Activity

Potent and selective GPR30 receptor agonist (Ki = 11 nM, EC50 = 2 nM); displays no activity at ERα and ERβ at concentrations up to 10 μM. Increases cytosolic Ca2+ and inhibits migration of SKBr3 cells and MCF-7 cells in response to chemoattractants (IC50 values are 0.7 and 1.6 nM respectively) in vitro. Blocks MCF-1 cell cycle progression at the G1 phase. Displays therapeutic effects in the mouse EAE model of multiple sclerosis.

Licensing Information

Not for sale in the USA.

Technical Data

M.Wt:
412.28
Formula:
C21H18BrNO3
Solubility:
Soluble to 100 mM in DMSO
Purity:
>98 %
Storage:
Store at -20°C
CAS No:
881639-98-1

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch
Select another batch:
Safety Data Sheet: View Safety Data Sheet

References

Bologa et al (2006) Virtual and biomolecular screening converge on a selective agonist for GPR30. Nature Chem.Biol. 2 207.

Albanito et al (2007) G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17β-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res. 67 1859. PMID: 17308128.

Blasko et al (2009) Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis. J.Neuroimmunol. 214 67. PMID: 19664827.

Ariazi et al (2010) The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. Cancer Res. 70 1184. PMID: 20086172.

If you know of a relevant citation for this product please let us know.

View Related Products by Target

Keywords: G-1, supplier, Potent, selective, G1, GPR30, agonists, receptors, estrogen, oestrogen, G, protein-coupled, receptor, 30

Quick Order

Find multiple products by catalog number

divider line

7-TM Receptor Signaling

Written by T. Kenakin et al

7-TM Poster

'Seven Transmembrane Receptor Signaling' highlights the multiple behaviors of 7-TMs including G-protein-dependent and -independent signaling as well as the concept of collateral efficacy

divider line

Estrogen Pathway

Estrogen Pathway

Estrogen controls many cellular processes including growth, differentiation and function of the reproductive system. View pathway or download PDF today.

divider line

New Product Guide

NPG

Highlights over 130 new products added in 2012. Request a copy or view PDF today.

divider line

New Products in this Area

CYM 50308

Potent and selective S1P4 agonist

H2L5186303

Potent and selective LPA2 receptor antagonist

MEDICA 16

FFA1 (GPR40) agonist. Also inhibits ATP citrate lyase

BX 471

Potent, selective CCR1 antagonist

PF 04418948

Potent and selective EP2 receptor antagonist

Latanoprost

FP prostaglandin receptor agonist; also exhibits agonist activity at EP1 and EP3 receptors

GRI 977143

Selective LPA2 receptor non-lipid agonist

CYM 50260

Potent and selective S1P4 agonist

G-36

Selective GPR30 antagonist

Strontium chloride

Calcium sensing receptor (CaSR) agonist

CS 2100

Selective S1P1 agonist

SMANT hydrochloride

Inhibits Smoothened (Smo) accumulation

TUG 891

Potent and selective GPR120 agonist

IT1t dihydrochloride

Potent CXCR4 antagonist

RuBi GABA trimethylphosphine

Caged GABA; inhibits neural activity

Sign-up for new product e-alerts
divider line

20% Discount*

Potent, selective LRRK2 inhibitor

Potent LRRK2 inhibitor now available from Tocris Bioscience

Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.

* Terms & conditions